As of 2026-02-18, the EV/EBITDA ratio of Global Blood Therapeutics Inc (GBT) is -16.85. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. GBT's latest enterprise value is 4,942.22 mil USD. GBT's TTM EBITDA according to its financial statements is -293.25 mil USD. Dividing these 2 quantities gives us the above GBT EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 15.2x - 15.9x | 15.4x |
| Forward P/E multiples | 13.7x - 31.1x | 20.8x |
| Fair Price | (70.64) - (73.77) | (83.42) |
| Upside | -203.1% - -207.7% | -221.8% |
| Date | EV/EBITDA |